Abstract. This study was conducted to examine the possibility of performing nuclear transplantation using parthenogenetically derived embryos as donor nuclei (karyoplasts) to support embryonic development after nuclear transplantation. The recipient oocytes (cytoplasts) were enucleated and then activated after maturation, and the donor blastomeres were obtained from 8-to 16-cell stage embryos of parthenogenetically activated and fertilized embryos. The fusion, cleavage and blastocyst rates of reconstructed embryos that received fresh parthenogenetic blastomeres were 90%, 96% and 13%, respectively. The in vitro development of these reconstructed embryos was not significantly different (P>0.05) from the reconstructed embryos, which received IVF-derived blastomeres (94%, 95% and 21%, for fusion, cleavage and blastocyst rates, respectively). In contrast, these values decreased, when the reconstructed embryos received frozen-thawed parthenogenetic blastomeres (74%, 93% and 0%, for fusion, cleavage and blastocyst rates, respectively). Moreover, the development of reconstructed embryos that received parthenogenetic blastomeres showed some fragmentation at the compaction stage, unincorporation of blastomeres and multiple cavities (blastocoeles) in the blastocyst stage. This preliminary study has demonstrated the developmental potency of parthenogenetic bovine embryo nuclei, which could develop to the blastocyst stage when transplanted into enucleated oocytes.
uring the last decade, nuclear transfer in mammals has been used as an important tool for the study of fundamental aspects of development. The technique of nuclear transfer involves the fusion of a single nucleated blastomere to a recipient cytoplast, which is prepared by enucleation of a metaphase II oocyte or a one-cell zygote. Parthenogenetic activation has been used widely in cloning by nuclear transplantation techniques to induce activation of the enucleated oocytes and also to induce fusion between donor -Research Notekaryoplast and cytoplast [1, 2] .
The induction of parthenogenesis in mammalian oocytes requires a calcium-releasing stimulus to complete the second meiotic division. Furthermore, exposure to protein synthesis inhibitors or broad spectrum protein kinase inhibitors enhances the resumption of mitotic cell division [3, 4] . Parthenogenesis has been induced in bovine oocytes by exposure to 7% (v/v) ethanol and subsequent culturing in a medium containing cycloheximide, and the resumption of embryonic cell cycles and a high percentage of blastocyst formation has been achieved [1, 5] . Usually, the post-implantation development of parthenogenetic embryos is characterized by poor development of trophectoderm derivatives [6] . Furthermore, it has been reported that defective cells are located in both the trophectoderm and the inner cell mass (ICM) [7, 8] .
In the early study of nuclear transplantation in the mouse, it was postulated that blastomeres of parthenogenetic embryos are unable to support development to term [9] . However, to date nuclear transplantation techniques in the bovine have very much improved and have permitted the development to term of bovine clone embryos, which are reconstructed with a somatic cell as a donor karyoplast. To our knowledge, there is no report about the use of parthenogenetic bovine embryos as donor nuclei in nuclear transplantation in the bovine. Therefore, in the present study, we investigated the possibility of performing nuclear transplantation using blastomeres of parthenogenetic bovine embryos as donor nuclei, and we report that the blastomeres of parthenogenetic bovine embryos are able to develop to the blastocyst stage after transplantation into enucleated oocytes.
Materials and Methods

Sources of embryos
Oocyte collection, in vitro maturation (IVM) and in vitro fertilization (IFV) were carried out as described by Boediono et al. [10] . Briefly, bovine ovaries were obtained from a local abattoir within 3 h after slaughter. Follicles 2-5 mm in diameter were aspirated with a 10 cc syringe fitted with an 18-gauge needle. The oocytes surrounded by cumulus cells were washed once in modified phosphate buffered saline supplemented with 50 µg/ml gentamicin sulfate (Sigma Chemical Co., USA), and three times in maturation medium which consisted of TCM 199 (Gibco, Grand Island, NY, USA) supplemented with 5% (v/v) heatinactivated fetal calf serum, 50 µg/ml gentamicin sulfate, 0.02 AU/ml follicle stimulating hormone (FSH, Denka Pharmaceutical Co., Kawasaki, Japan). The incubation of cumulus oocyte complexes (COCs) in maturation medium was conducted at 38.5 C in a humidified atmosphere of 5% CO2 in air for 22 h.
Twenty two hours after the onset of IVM, 10-20 COCs were placed into 100 µl of sperm suspension at a concentration of 5 × 10 6 cells per ml. Sperm and COCs were incubated for 5 h at 38.5 C in 5% CO 2 in air. After washing three times in culture medium, the 10-20 COCs were transferred into 500 µl of culture medium [CR1aa supplemented with 5 µg/ml insulin, 5 µg/ml transferring, 5 ng/ml sodium selenite (Sigma Chemical Co., USA), and 5% (v/v) FCS]. The COCs were cultured for 8 days (for the control of IVF embryos) and 72 h for the control of the reconstructed embryos that received fertilized blastomeres.
Parthenogenetic embryos were prepared by artificial activation as described by Yang et al. [1] , with minor modification. Briefly, 33 h after the onset of maturation, COCs were washed twice in CR1aa, and the oocytes with remnant cumulus cells were incubated in CR1aa medium supplemented with 7% (v/v) ethanol for 10 min. This was followed by culture in CR1aa medium which contained 5 µg/ml of cytochalasin B (Sigma Chemical Co., USA) and 10 µg/ml cycloheximide (Wako Pure Chemical Industries Co., Ltd., Osaka, Japan) for 6 h. Subsequently, the oocytes with the remnant oocytes were washed with culture medium before being cultured for 8 days (for the control of parthenogenetic embryos). The donor karyoplasts were prepared from 8-to 16-cell stage embryos.
Embryo cryopreservation
Parthenogenetic embryos at the 8-cell stage were cryopreserved as described by Takagi et al. [11] . Briefly, the embryos were directly exposed to the cryoprotectant (1.8 M ethylene glycol in PBS) and equilibrated for 5 min at room temperature. Following equilibration, 4-5 embryos were loaded into 0.25 ml plastic straws. After loading, the straws were placed into a programmable freezer (ET-1, Fujihira Industries Co. Ltd., Tokyo) maintained at 0 C and cooled to 7 C at a rate of 1 C/min. The straws were seeded at 7 C with cooled forceps, and held at this temperature for 10 min. After seeding, the straws were cooled at a rate of 0.3 C/min to 30 C, and then immediately plunged into and stored in liquid nitrogen. After 1-2 weeks of storage, the embryos were thawed in a water bath at 30 C. The cryoprotectant was removed using the direct rehydration method. The embryos and small amounts of cryoprotectant were added to culture medium and washed several times, and then cultured overnight in culture medium, before being used as donor karyoplasts. Only blastomeres with intact membrane were used as donor karyoplasts.
Embryo manipulation and nuclear transplantation
At 20 h after the onset of in vitro maturation, cumulus cells were removed by culturing the COCs in PBS( ) containing 10 µg/ml hyaluronidase (Sigma Chemical Co., USA) for 2 min followed by manual pipetting to remove the remaining cumulus cells. Cumulus cell-free oocytes were washed three times in manipulation medium, which consisted of PBS(+) supplemented with 5 µg/ml cytochalasin B and 5% (v/v) FCS, and were held in this medium for at least 20 min at room temperature before being enucleated. The zona pellucida of the recipient oocyte was cut by a sharp glass needle before enucleation. Enucleation of the metaphase plate chromosome was accomplished by microsurgical enucleation of the first polar body and a small amount of the cytoplasm adjacent to the first polar body, using a 35 µm (outer diameter) non-beveled glass pipette. Confirmation of the enucleation of the metaphase plate chromosome was carried out by staining the cytoplast with 10 µg/ml Hoechst 33342 (Sigma Chemical Co., USA) in PBS(+), for 20 min and observing under a fluorescence microscope within a few seconds. At 33 h after the onset of in vitro maturation, the cytoplasts were artificially activated by two DC pulses of 0.75 KV/ cm for 50 µsec, and then cultured for a further 9 h in CR1aa medium, until the nuclear transplantation process, i.e. 42 h after maturation.
The donor karyoplasts were prepared from 8-to 16-cell stage embryos. The zona pellucida of the donor embryos was removed by cutting it with a glass needle in a 20 µl drop of PBS(+) supplemented with 5 µg/ml cytochalasin B and 5% (v/v) FCS. The zona-excised embryos were then exposed to PBS( ) supplemented with 5% (v/v) FCS for a few minutes, and then the blastomeres were isolated into single blastomeres by pipetting.
The donor karyoplast was inserted into the perivitelline space of a recipient cytoplast through the slit in the zona pellucida. The cells were wedged between the zona and the cytoplast membrane to facilitate membrane contact prior to fusion. The reconstructed embryos were incubated in fusion medium (0.3 M manitol, 0.05 M CaCl2 and 0.1 M MgSO 4 .7H 2 O) for 5 min before electrofusion. Cell fusion was performed in a chamber with two stainless steel electrodes 1 mm apart overlaid with fusion medium. The reconstructed embryos were manually aligned with a fine, mouth-controlled microcapillary pipette so that the contact surface between the cytoplast and the donor cell was parallel to the electrodes. Cell fusion was induced with a single DC pulse of 0.75 kV/cm for 100 µsec, delivered by a BTX Electro Cell Manipulator 2001 (BTX, San Diego, CA). Following the fusion, the reconstructed embryos were washed in CR1aa medium supplemented with 5% (v/v) FCS. They were then incubated in CR1aa medium supplemented with 5% (v/v) FCS and 7.5 µg/ml cytochalasin B for 1 h. Fusion was then determined by microscopic examination prior to in vitro culture.
Embryo culture
Embryo culture was performed using a loose suspension culture system, as described by Sims and First [12] . Following culture in medium that contained cytochalasin B, the reconstructed embryos were washed three times in culture medium, then 5-10 reconstructed embryos were cultured in 100-µl drops of culture medium, and were cultured for 7-9 days at 38.5 C under 5% CO 2 in air. For the IVF and parthenogenetic embryo controls, the COCs were cultured in 500 µl drops of culture medium. The in vitro development of the reconstructed embryos was recorded every 48 h after fusion until day 8 of culture.
Data analysis
The data were analyzed using chi-squared test and differences at p<0.05 were considered significant.
Results
Ninety-one reconstructed embryos that received fresh or frozen parthenogenetic blastomeres, and 109 reconstructed embryos that received IVFderived blastomeres were used in this experiment. The fusion and cleavage rates of the reconstructed embryos that received fresh parthenogenetic blastomeres were not significantly different (p>0.05) from those that received fresh IVF-derived blastomeres. The fusion rates for reconstructed embryos that received frozen-thawed parthenogenetic and frozen-thawed IVF-derived blastomeres were lower than those of the other treatments (p<0.05). The cleavage rates of reconstructed embryos that received fresh parthenogenetic and IVF-derived blastomeres were significantly higher (p<0.05) than the control of parthenogenetic and IVF-produced embryos ( Table  1) . The rate to blastocysts development in the reconstructed embryos that received fresh parthenogenetic and IVF-derived blastomeres was not significantly different (p>0.05) from that in the control of parthenogenetic embryos (17%), but was significantly lower (p<0.05) than the control of IVFembryos (29%).
The rate of development in the reconstructed embryos that received frozen-thawed IVF-derived blastomeres was similar to those of the reconstructed embryos that received fresh parthenogenetic blastomeres or fresh IVF-derived blastomeres. However, none of the reconstructed embryos that received frozen-thawed parthenogenetic blastomeres developed to the morula stage (data not shown in Table 1 ).
The morphology of the early development of the reconstructed embryos receiving parthenogenetic blastomeres until the pre-compaction stage was not different from the reconstructed embryos that received IVF-derived blastomeres. However, in subsequent development, the reconstructed embryos that received these karyoplasts showed unclear compaction. Fragmentation of the blastomeres was observed at the compaction stage, and the embryos that reached the blastocyst stage had several blastomeres that were not incorporated, showed multiple cavitation, and had small blastomeres extruding into the blastocoele cavity (Fig. 1) .
Discussion
The reconstruction of embryos by transfer of a donor karyoplast to an enucleated oocyte or pronuclear zygote cytoplast has been accomplished in a variety of mammalian species. The development to term of nuclear transplanted embryos has clearly shown that an enucleated cytoplast or enucleated-fertilized cytoplasm has the ability to alter the genomic function the transplanted nuclei. The present study shows that nuclei from parthenogenetically derived embryos apparently are capable of being reprogrammed by recipient cytoplasm, and obtained the ability to develop to the blastocyst stage.
Although it has been denied, the production of homozygous diploid mice has been attempted by transferring the nuclei of parthenogenetic embryos into enucleated-fertilized oocytes [13] . Unfortunately, the precise mechanism that regulates the interaction of donor nucleus and recipient cytoplast is not well understood. In the bovine, it has been reported that parthenogenetic embryos have the capability to develop to the preimplantation stage [14] . In our study, 59% of the parthenogenetically activated oocytes cleaved and 17% of them developed to the blastocyst stage. The rates of fusion with a cytoplast and subsequent cleavage in the case of 8-to 16-cell stage parthenogenetic embryos used as a donor karyoplast (90% and 96%, respectively) were not significantly different from those in the case of reconstructed embryos that received IVF-derived blastomeres (94% and 95%, respectively). However, the cleavage rate of the reconstructed embryos was significantly higher than the cleavage rate of the control of parthenogenetic embryos (59%) or IVF embryos (73%). Furthermore, the subsequent in vitro development of these reconstructed embryos to the blastocyst stage (13%) was not significantly different (p>0.05) from the reconstructed embryos that received IVF-derived blastomeres (21%), reflecting that the nuclei of bovine parthenogenetic embryos have a developmental potency similar to the IVF-derived nuclei. The blastocyst rate of the reconstructed embryos that received parthenogenetic and IVF-derived blastomeres was low (13% and 21%, respectively) compared with the IVF embryos (29%), and the development of the reconstructed embryos stopped at the border of 8-16 cell stages. Several factors might affect these results: the absence of a cocultured system [15] , exposure of the recipient cytoplast to UV light [16] [17] [18] , or chromosomal aneuploidy in the reconstructed embryos [19] . The difficulty of obtaining diploid chromosome on the parthenogenetic embryo [20] and the lack of synchronization of the cell cycles between the donor karyoplast and the recipient cytoplast may be a partial explanation of the low development of the reconstructed embryo [19] .
It has been reported that frozen-thawed and fresh blastomeres had equivalent developmental potency when they were used as donor karyoplasts in nuclear transplantation [15, 21] . In our study, the rates of development in the reconstructed embryos that received frozen-thawed IVF-derived embryos support the evidence of previous reports. However, in this study we were unable to develop the reconstructed embryos that received frozenthawed parthenogenetic blastomeres to the blastocyst stage. These findings show that freezethawing of parthenogenetic embryos reduced the developmental competence of parthenogenetic blastomeres.
This preliminary study indicates that bovine parthenogenetic blastomeres can be used as donor karyoplasts and that the resultant reconstructed embryos are capable of developing to the blastocyst stage. Nevertheless, further study on the subsequent in vivo development must be performed by transferring the blastocyst to a foster mother to show whether or not nuclear transplantation permits sufficient modification in transferred nuclei derived from parthenogenetic embryos. A B
